Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

The identification of risk factors associated with patient and healthcare system delays in the treatment of tuberculosis in Tabriz, Iran

  • 1,
  • 2,
  • 1,
  • 1,
  • 1,
  • 3, 4 and
  • 1Email author
BMC Public HealthBMC series – open, inclusive and trusted201818:174

https://doi.org/10.1186/s12889-018-5066-9

  • Received: 17 April 2017
  • Accepted: 11 January 2018
  • Published:
Open Peer Review reports

Abstract

Background

Tuberculosis (TB) is a serious health concern, particularly in developing countries. Various delays, such as patient delay (PD) and healthcare system delay (HSD) in the TB process, are exacerbating the disease burden and increasing the rates of transmission and mortality in various global communities. Therefore, the aim of this study is to identify risk factors associated with PD and HSD in TB patients in Tabriz, Iran.

Methods

A cross-sectional study was conducted on 173 TB patients in Tabriz, Iran from 2012 to 2014. Patients were interviewed with a semi-structured questionnaire. Frequencies and percentages were reported for patient categories of sex, age, and education. The median and interquartile range (IQR) were reported for the time intervals of delays. Univariate and multivariate logistic regressions of delay in respect to socio-demographic and clinical variables were performed. Statistical significance was set at p < 0.05.

Results

The median values for delays were 53 days for HSD (IQR = 73) and 13 days for PD (IQR = 57). Odds ratios (OR) associated with PD were: employed vs. unemployed (OR = 5.86, 95% CI: 1.59 to 21.64); public hospitals vs. private hospitals (OR = 2.64, 95% CI: 1.01 to 6.85); ≥ 3 vs. < 3 visits to health facilities before correct diagnosis (OR = 2.35, 95% CI: 1.08 to 5.11); and male vs. female (OR = 2.28, 95% CI: 1.29 to 4.39). The OR associated with HSD were: ≥ 3 vs. < 3 visits to health facilities before correct diagnosis (OR = 9.44, 95% CI: 4.50 to 19.82), without vs. with access to TB diagnostic services (OR = 3.56, 95% CI: 1.85 to 6.83), and misdiagnosis as cold or viral infection vs. not (OR = 2.62, 95% CI: 1.40 to 4.91).

Conclusions

The results provide for an important understanding of the risk factors associated with PD and HSD. One of the major recommendations is to provide more TB diagnostic knowledge and tools to primary health providers and correct diagnoses for patients during their initial visit to the health care facilities. The knowledge generated from this study will be helpful for prioritizing and developing strategies for minimizing delays, initiating early treatment to TB patients, and improving TB-related training programs and healthcare systems in Tabriz, Iran.

Keywords

  • Tuberculosis
  • Patient delay
  • Healthcare system delay
  • Delay
  • Tabriz
  • Iran

Background

Tuberculosis (TB) is a global public health problem that continues to remain a serious health concern, particularly for developing countries [13], and is being confronted with aggressive global strategies for monitoring and control [4, 5]. According to the TB global report in 2015, there were an estimated 10.4 million incident cases and 1.8 million deaths from TB [2]. More than 95% of TB deaths occur in low- and middle-income countries [6]. For more than a decade, the World Health Organization (WHO) has introduced various programs to improve the quality of directly observed treatment, short-course strategy (DOTS) and reducing the burden of TB globally [2, 4, 6, 7]. Although efforts for treatment and diagnostic approaches for active TB have been aggressively pursued [8, 9], health care systems are still having conspicuous problems with timely diagnosis and proper treatment [1, 10]. Without proper treatment, a TB patient, on average, can infect 15–20 people annually [4]. Therefore, early diagnosis and effective treatment are fundamental elements that need to be addressed for all national TB programs (NTP) [1].

A primary goal of every NTP is to stop the transmission of TB within the community, by minimizing the time between onset of symptoms and DOTS initiation [11, 12]. Previous studies have shown that the factors of patient delay (PD) and healthcare system delay (HSD) in TB diagnosis and treatment increase the probability of TB transmission in the community as well as the mortality rate [10, 13, 14]. The issue of HSD of TB is a crucial challenge in both developed and developing countries [15], and HSD may be considered as a measure of the level of TB awareness and the efficiency of the country’s NTP [10].

Nine countries contributed a total of 95% of TB burden in Eastern Mediterranean region in 2010. These countries were Pakistan, Afghanistan, Sudan, Morocco, Somalia, Iraq, Egypt, Yemen, and the Islamic Republic of Iran [16]. In a region-based study by WHO in 2006 [17], the Islamic Republic of Iran contributed only 6% of the TB burden to the Eastern Mediterranean Region (EMRO) with a wide range of overall delay (OD) (5–728 days). In this region-based study, with a total sample size of 5053 patients, Iran contributed 800 TB patients, from which more than half of them (51%) reported a delay between the onset of symptoms and treatment [17]. Even though Iran is considered as an upper-middle-income country [18] with an advanced healthcare system [19], it borders on countries with high levels of TB prevalence including Iraq, Afghanistan, Pakistan, and newly independent countries from the former Soviet Union. These border countries present a particular challenge for the Iranian NTP [20, 21]. Therefore, it is imperative to reduce TB treatment delays in Iran so as to improve the Iranian NTP, and to mitigate transmissions into Iran from external sources.

Current literature does not provide an accepted “time interval” definition of delays for TB patients [22, 23]. Evaluations and reasons for delays can be as diverse as the various local health facilities and regional epidemiological aspects of TB [24]. One study reported that the main delay of TB diagnosis and treatment in Iran was the time taken by medical doctors to diagnose TB in symptomatic patients [25]. Moreover, a study in northern Iran demonstrated that the knowledge about diagnosis, treatment, and monitoring of TB in medical students was poor [26]. Another study showed that only 57% of all TB patients in Iran are diagnosed correctly when first attending a healthcare facility [20], which is far below the WHO target objective of 70% case detection of TB from 1997 onwards [27]. The WHO target objective is essential for all NTPs, worldwide, as relates to an overall goal for eliminating TB from the human population [6].

There is much variability across studies regarding the time interval of delays in TB patients [12, 2832]. Two systematic reviews conducted across sets of multiple studies have reported medians of PD and HSD to range from 6 to 267.7 days and 2-120 days, respectively [23, 33]. Various factors have been reported as predictors for PD and HSD including lower education (PD) [34], being female (PD), being male (HSD), smoking (PD), older age (PD), initial visit to the private sector (HSD), cough (PD) [10, 11, 14, 27, 35, 36], history of contact with TB patient (HSD) [37], financial problem (HSD), consultation at a public hospital before diagnosis (HSD) [38], and visiting healthcare facilities more than once (PD) [1] or twice (HSD) [36, 39].

To the best of our knowledge, the potential risk factors associated with PD and HSD have not been extensively researched in the northwest of the Iran which includes Tabriz, a city with a population of around 1.5 million [40]. Tabriz has only one dedicated Tuberculosis and Lung Diseases Research Center (TLDRC). In Iran, typical procedures for TB diagnosis are as follows: general physicians from private and public hospitals/clinics can diagnose TB based on patients’ symptoms; however, all TB cases need to be referred to a TLDRC for further laboratory tests and final confirmation of diagnosis. Furthermore, DOTS treatment to patients is given at TLDRC. Even though this region of Iran is not considered to have a high burden of TB, it is important to note that, in the regions where TB cases are not common, it is generally difficult to attain a high degree of immediate treatment action by healthcare facilities [10]. Therefore, identifying the source of delay in Tabriz and the surrounding northwest region of Iran is crucial for early diagnosis and proper treatment of TB locally [2]. The aim of this study was to identify the time intervals of delays and to predict associated risk factors for TB in Tabriz, Iran. In this study, the OD is split into PD and HSD, so as to allow a better identification of risk factors associated with these two types of delays [41].

Methods

Study design, setting, and participants

This cross-sectional study was conducted in Tabriz, the capital city of East Azerbaijan province at the northwest of Iran. All eligible diagnosed pulmonary TB patients who had medical records at the TLDRC in Tabriz from 2012 to 2014 participated in the study. Pulmonary TB cases were defined based on both WHO and Iranian national TB guidelines [9, 12, 42]. Bacteriological confirmation was not used as an inclusion criterion for the present study, but all patients had to receive a TB DOTS for 6 months from a TLDRC. This study was approved by the Students Research Committee (No. 5/46/210) and Ethical Regional Committee (No. 5/4/9632) of Tabriz University of Medical Sciences and Health Services, Tabriz, Iran. The Institutional Review Board at the North Carolina Agricultural and Technical State University (NCAT) received the approved letters.

Patients were aware of the objectives, steps, and expected outcomes of the research. All patients who participated in this study signed the written informed consent. Overall, 185 TB patients were admitted to the TLDRC from January 2012 to December 2014. Only patients aged over 18 years old were recruited for the study. TB patients with foreign nationality, previous history of TB therapy equal to or more than twice, and prisoners who were imprisoned during the study period were excluded from this study. After exclusion, a total of 173 TB patients were included for further data analysis in this study.

Data collection

Data were collected using the standardized questionnaire from WHO’s EMRO study [1], which was translated into Persian for members of the Iranian population. All TB patients were registered in the NTP system (NTP) when they first attended TLDRC in Tabriz, Iran. Clinical and socio-demographic information was obtained from the NTP after receiving the verbal informed consent from patients through the phone. Information associated with risk factors of PD and HSD in TB patients was collected through the interview process after receiving written informed consent from patients. The interviews were performed at each patient’s home. Patients were informed about the objectives and significance of the study before the interview.

Definitions

Directly observed treatment, short-course (DOTS)

This is a strategy used to reduce the incidence and spread of tuberculosis (TB) cases. This strategy has two goals, to ensure that the TB patient completes the anti-TB regimen, to best promote healing and cure; and to prevent drug resistance that can otherwise occur from improper and incomplete use of anti-TB drugs [43]. The time interval from the inception of symptoms until the initiation of DOTS strategy is defined as overall delay (OD), which is the sum of two delays, PD and HSD (Fig. 1).
Fig. 1
Fig. 1

Conceptual framework of delays and their definitions (modified from a WHO region-based study) [17]. PD: patient delay; HSD: health care system delay; and OD: overall delay. DOTS: directly observed treatment, short-course

Patient delay (PD)

The time interval (in days) from the onset of symptoms until first attending healthcare facilities.

Healthcare system delay (HSD)

The time interval (in days) between the date of initial presentation at a healthcare facility and the initiation of the DOTS regimen.

Primary health care (PHC)

This level of care involves family physicians (general practitioners) who provide systematic referral to other levels of care such as secondary health care (SHC) or tertiary health care (THC) for situations needing more specialized diagnosis and treatment.

Secondary health care (SHC)

This level of care is a specialized unit within the healthcare system. Health workers provide outpatient or inpatient treatment as well as rehabilitation services for those referred from primary health care practitioners.

Tertiary health care (THC)

This level of care involves specialized consultative outpatient or inpatient treatment that is at an especially advanced level for specialized surgeries, rehabilitation services, and provisioning of medicines, other medical supplies and laboratory services.

Statistical analysis

The analysis was performed in five steps. First, frequency and percentage were calculated for categorical variables such as age, gender, education and occupation, while medians and inter-quartile ranges (IQR) were calculated for continuous variables with a non-normal distribution. Consistent with previous studies, the cutoff points for delays were defined as the median value obtained for each delay [1, 10, 14, 44]. Less than or equal to median was considered as “without delay” and greater than median was considered as “with delay”. Second, the new and retreated TB patients (with only one course of previous treatment) were not separated in the current study, because there was no significant difference between them tested by Kaplan-Meier survival analysis. Third, to test the association between delays (presence: delays >median, absence: delays ≤ median) with categorical variables, the Pearson’s chi-square or the Fisher’s exact test was applied at α = 0.05 level. Association between delays (absence, presence) with the type of healthcare system (private or public) were made using the Mood’s median test at α = 0.05 level. Next, to investigate the potential risk factors associated with delays, univariate and multivariate analyses were applied. The one-way analysis of variance (ANOVA) was used to determine the impact of various level of the health care facilities on the diagnosis of TB. Finally, to evaluate adjusted odds ratios and corresponding 95% Confidence Intervals (95% CI) for risk factors of HSD and PD, the multivariate logistic regression was applied. Factors associated with delays were analyzed using multivariate regression analysis [14, 22, 45]. Data analysis was conducted using the Statistical Packages for the Social Sciences (SPSS) version 22 (Released 2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp). The level of significance was considered at α = 0.05.

Results

Socio-demographic and clinical characteristics of the participants

The mean age of the patients was 55.6 years old (median 59, range 18-90). Among all participants, 88 (50.9%) were male and 85 (49.1%) were female. Among all participants, 79 (45.7%) were illiterate, 84 (48.6%) unemployed, and 106 (61.3%) married. As shown in Table 1, the median (IQR) of PD and HSD were 13 (57) and 53 (73), respectively.
Table 1

Descriptive statistics of PD and HSD (days) in TB patients. Tabriz, Iran 2012-2014

Type of delaya

PD

HSD

Mean (SDb)

46.2 (82.5)

75.3 (89.2)

Median (IQRc)

13 (57)

53 (73)

Range

0-453

1-726

aAll delays are based on days. bStandard Deviation. cInterquartile range

About 93 (58.5%) of the patients attended clinics or hospitals three or more times between the onset of symptoms and the time at which they were diagnosed with TB. The major symptoms that motivated patients for their first-time visit to the health care facilities were coughing, for 170 (98.3%) of the patients, and unusual sputum, for 161 (93.1%) of the patients. About 102 (59%) of the patients were misdiagnosed as having a cold or viral infection, 13 (7.5%) were misdiagnosed as having asthma, and 10 (5.8%) were misdiagnosed as having chronic obstructive pulmonary disease (COPD).

There was a significant association between misdiagnosis as cold or viral infection and the different level of healthcare facility (Table 2). Misdiagnoses as cold or viral infection in TB patients, upon their first-time visit to a healthcare facility, varied significantly based upon type of facility: PHC (58.8%), SHC (36%), and THC (4.6%) (p < 0.001). Misdiagnosis as asthma was also statistically significant at these different varieties of facilities (p < 0.003). The PHC facilities contributed to 50% of the first-time correct diagnoses of TB that were referred to TLDRC, and the SHC and THC facilities contributed to 34.6% and 15.4% of first-time correct diagnoses, respectively. In 173 of the patients studied, only 26 (15%) of the patients were correctly diagnosed as TB in their first visit to health facilities.
Table 2

Diagnosis before TB confirmation by the level of health care facilities in TB patients, Tabriz, Iran 2012-2014

First diagnosis

PHCa N (%)

SHCb N (%)

THCc N (%)

P-value e

TB (N = 26)

13 (50)

9 (34.6)

4 (15.4)

0.658

Cold or viral infection (N = 102)

60 (58.8)

37 (36.3)

5 (4.6)

< 0.001

Asthma (N = 13)

4 (30.8)

3 (23.1)

6 (46.2)

0.003

COPDd (N = 10)

4 (40)

6 (60)

0 (0.0)

0.199

Others (N = 21)

6 (28.6)

12 (57.1)

3 (14.3)

0.139

aPrimary Health Care, bSecondary Health Care, cTertiary Health Care, dCOPD: Chronic Obstructive Pulmonary Disease. eP-values are based on Analysis of Variance (ANOVA) test

Factors associated with patient delay (PD)

Patients’ opinions on possible personal reasons for delay in visiting health facility for receiving diagnosis and treatment are shown in Fig. 2. There were 43.4% of the patients who thought that the inappropriate reaction of health services provider was one of the reasons for delayed diagnosis and treatment of TB; 43.1% were scared about presumptive diagnosis; and 73% mentioned that they thought their disease was a regular cold and hoped to recover.
Fig. 2
Fig. 2

Patients’ opinions on possible reasons of delay in diagnosis and treatment of TB in Tabriz, Iran, 2012-2014

Clinical and demographical factors associated with PD are described in Table 3. PD was significantly more frequent among male compared to female patients. (61.4% vs. 38.6%; p < 0.005). The significant risk factors for PD were being employed (5.86-fold increased risk), attending public hospitals or clinics for the first time after the onset of TB symptoms (2.64-fold increased risk), and being male (2.28-fold increased risk). Age, marital status, educational level, history of TB contact, economical affordability of diagnostic services, and misdiagnosis were not strongly associated with the risk of PD. Table 4 indicated that 66.2% of patients attending public hospitals or clinics had PD compared to the 35% of patients attending private hospitals or clinics (p < 0.05).
Table 3

The risk factors associated with patient and health care system delay in TB patients in Tabriz, Iran 2012-2014 (N = 173)

 

Number (%)

Patient delaya

Health care system delayb

Factors

 

N (%)c

Crude OR (95% CI)

N (%)c

Crude OR (95% CI)

Gender

 Female

85 (49.1)

33 (38.8)

1

48 (56.5)

1

 Male

88 (50.9)

53 (60.2)

2.28 (1.29 to 4.39)*

37 (42.0)

0.55 (0.30 to 1.022)

Age group

 ≤ 30

41 (23.7)

16 (39)

1

21 (51.2)

1

 > 30

132 (76.3)

70 (53)

1.76 (0.86 to 3.60)

64 (48.5)

1.11 (0.55 to 2.24)

Education

 Illiterate/W&Rd †

79 (45.7)

40 (50.6)

1

41 (51.9)

1

 Primary-Secondary

55 (31.8)

29 (52.7)

1.08 (0.54 to 2.16)

23 (41.8)

0.66 (0.33 to 1.33)

 University/Higher

39 (22.5)

17 (43.6)

0.75 (0.348 to 1.63)

21 (53.8)

1.08 (0.501 to 2.333)

Occupation

 Unemployed

84 (48.6)

40 (47.8)

1

47 (56.0)

1

 Employed

19 (11.0)

16 (84.2)

5.86 (1.59 to 21.64) *

8 (42.1)

0.57 (0.20 to 1.56)

 Student

14 (8.1)

2 (14.3)

0.18 (0.03 to 0.87) *

11 (78.6)

2.88 (0.75 to 11.10)

 Retired

36 (20.8)

18 (15.0)

1.10 (0.50 to 2.40)

12 (33.3)

0.39 (0.17 to 0.89) *

 Farmer

20 (11.6)

10 (50.0)

1.10 (0.415 to 2.91)

7 (35.0)

0.42 (0.154 to 1.16)

Marital status

 Married

106 (61.2)

52 (49.5)

1

47 (44.3)

1

 Single

29 (16.8)

14 (48.3)

0.96 (0.42 to 2.20)

15 (51.7)

1.34 (0.59 to 3.06)

 Divorced

6 (3.5)

5 (83.3)

5.19 (0.58 to 45.95)

3 (50.0)

1.25 (0.24 to 6.50)

 Widow/death

32 (18.5)

15 (46.9)

0.91 (0.41 to 2.02)

20 (62.5)

2.09 (0.92 to 4.71)

Smoking

 Never

70 (40.5)

3 (45.7)

1

34 (48.6)

1

 Current

75 (43.4)

39 (52.0)

1.28 (0.67 to 2.47)

38 (50.7)

1.08 (0.56 to 2.08)

 Ex-smoker

28 (16.2)

15 (53.6)

1.37 (0.56 to 3.30)

13 (46.4)

0.91 (0.38 to 2.208)

Household size

 < =3 people

67 (38.7)

38 (56.7)

1

30 (44.8)

1

 > 3 people

106 (61.3)

48 (45.3)

1.58 (0.85 to 2.93)

55 (51.9)

0.75 (0.40 to 1.38)

History of TB contact

 Yes

35 (20.2)

13 (37.1)

1

13 (37.1)

1

 No

138 (79.8)

73 (52.1)

1.901 (0.88 to 4.07)

72 (52.2)

1.84 (0.86 to 3.95)

First misdiagnosis

Cold or viral infection

 No

71 (41.0)

39 (54.9)

1

26 (35.2)

1

 Yes

102 (59.0)

47 (46.1)

1.42 (0.77 to 2.62)

60 (58.8)

2.61 (1.40 to 4.91)*

Asthma

 No

160 (92.5)

80 (50.0)

1

77 (48.1)

1

 Yes

13 (7.5)

6 (46.2)

1.16 (0.37 to 3.62)

8 (51.5)

0.58 (0.18 to 1.84)

COPD

 No

163 (94.2)

82 (50.3)

1

80 (49.1)

1

 Yes

10 (5.8)

4 (40.0)

1.51 (0.41 to 5.58)

5 (50.0)

0.96 (0.26 to 3.45)

The number of attending health care facilities

 < 3

65 (41.4)

36 (55.4)

1

15 (18.1)

1

 ≥ 3

93 (58.6)

37 (50.7)

0.54 (0.28 to 1.03)

68 (81.9)

9.44 (4.50 to 19.82)**

Center of first contact

 Traditional healer

6 (3.5)

3 (50)

1

4 (66.7)

1

 Public

77 (44.5)

51 (66.2)

2.64 (1.01 to 6.85)*

36 (46.8)

0.43 (0.7 to 2.5)

 Private

90 (52.0)

32 (35.6)

0.55 (0.10 to 2.89)

45 (50.0)

0.50 (0.08 to 2.8)

Level of health care facilities

 PHCe†

83 (48.0)

44 (53.0)

1

43 (51.8)

1

 SHCf

71 (41.0)

34 (47.9)

0.81 (0.43 to 1.53)

31 (43.7)

0.72 (0.38 to 1.36)

 THCg

19 (11.0)

8 (42.1)

0.64 (0.23 to 1.76)

11 (57.9)

1.27 (0.46 to 3.50)

Financial affordability for diagnostic tests

 Yes

66 (38.2)

39 (59.1)

1

20 (30.3)

1

 No

107 (61.8)

47 (43.1)

0.54 (0.29 to 1.01)

65 (60.7)

3.56 (1.85 to 6.83)**

Reference category, aPatient delay > 13 days, bHealth care system delay> 52 days, cAll percentages are reported within dependent variables (associated risk factors), dWriting and reading, *p < 0.05, ** p < 0.001, ePrimary Health Care, fSecondary Health Care, gTertiary Health care

P-values are based on binomial logistic regression. OR indicates odds ratio, CI confidence interval

Table 4

Difference observed in various delays between private and governmental clinics/hospitals in TB patients in Tabriz, Iran 2012-2014

Type of Delay

Public Hospital/Clinics N = 77

Private Hospital/Clinics N = 90

P-value

Patient delay

Yes N (%)a

51 (66.2)

32 (35.0)

0.001

Range (days)

0-365

0-453

Health care system delay

Yes N (%)b

36 (46.7)

45 (50)

0.62

Range (days)

1-425

1-726

aMedian PD > 13 days, bmedian HSD >53 days, P-value is based on Mood’s median test

Factors associated with health care system delay (HSD)

Of 173 TB patients, 85 (49.5%) had HSD. Factors associated with HSD by clinical and demographical characteristics are described in Table 3. Attending health care facilities ≥ 3 times before TB diagnosis (9.44-fold increased risk), misdiagnosis as cold or viral infection (2.61-fold increased risk), and financial unaffordability for receiving diagnostic services (3.56-fold increased risk) were significant risk factors for HSD. The HSD in those TB patients that first attended private hospitals or clinics was more than the HSD in patients that first attended public hospital or clinic after the onset of symptoms (52.9% vs. 42.4%); however, the difference was not statistically significant. Being retired was a protective factor for HSD. There was no statistically significant relationship between the type of occupation as a risk factor and HSD. Age, marital status, being a smoker, educational level, and the history of TB contact did not appear to be related to HSD.

Discussion

The present study identified the potential risk factors associated with PD and HSD for TB patients in the Tabriz, Iran. The major findings of the study are: (a) statistically significant risk factors for PD include: visiting public hospital/clinics (compared to private hospitals/clinics) after onset of symptoms; being employed (compared to being retired, unemployed, or being a homemaker), and being male; (b) statistically significant risk factors for increased HSD include: initial misdiagnosis as cold or viral infection, visiting any variety of health care facilities ≥ 3 times before diagnosis as TB, and financial unaffordability of diagnostic services; and (c) statistically significant risk factors for OD include: attending health care facilities ≥ 3 times before TB diagnosis, cold or viral infection, and financial unaffordability of the diagnostic services.

Time interval and potential risk factors associated with PD

In this study, almost half of the patients (49.7%) had PD. The median time for the PD in this study was less than that in the national study of Iran (13 vs. 26 days) [17], possibly because of differing time periods of the studies (2006 vs. 2014) or no local regions, such as Tabriz, being separated in the national study. However, in a study done in Iran’s capital city (Tehran), the median PD was similar to the current study of Tabriz region [25]. Studies in other countries reported varying time intervals of the PD from 6 to 267.7 days [24, 33, 4648]. In this study, the median of PD was almost similar to Egypt (12 days), Malaysia (14 days), and Ethiopia (15 days) [1, 25, 4951], and lower than Nepal (50 days), Somalia (53 days), and China (93 days) [1, 5254], and higher than Italy (7 days), Pakistan (9 days), and Taiwan (7 days) [1, 48, 55]. Therefore, PD is dependent on the country.

In agreement with previous studies, risk factors such as being a male, being employed, visiting health care facilities ≥3 times, and attending public hospitals (government hospitals) for the first time prior to diagnosis of TB were attributed to an increased PD [1, 15, 5658]. Attending public hospitals was a risk factor for PD possibly because public hospitals are associated with prolonged waiting times, a high number of patients with diverse diseases, and lack of an adequate number of trained physicians. No significant association was observed between PD and financial unaffordability in receiving diagnostic tests. This could be explained by the fact that all TB treatment procedures in Iran are free, and are based on Iran’s NTP [42], from a patient first attending TB center until receiving adequate treatment by a physician. The risk for PD was not found to be related to a patient’s smoking status (current and ex-smoker), consistent with similar studies in Argentina and Mozambique [39, 59], and contrary to the findings of a study from the southern part of Iran [60]. In general, the PD in Iran is comparable to that in other developing and some developed countries [51]. However, since there is no defined time of delay in diagnosis and treatment of TB worldwide, this can be different based on population and the setting of study.

Time interval and potential risk factors associated with HSD

The potential risk factors associated with HSD have never been explored for Tabriz, Iran. Even though this region is not considered as having a high rate of incidence for TB, we found that the median of HSD in this region of Iran is higher than national value (52 vs. 42 days) [1]. Based on previous studies, there is a wide range of median HSD values, from 2 to 120 days, in industrialized and developing countries [15, 17, 23, 6163]. In this study, the median HSD was almost similar to studies in Malaysia (49 days), Vietnam (53 days), and New Zealand (49 days) [49, 62, 64]; lower than Mozambique (62 days), Pakistan (87 days), and Columbia (> 60 days) [1, 39, 52, 65]; and higher than Taiwan (29 days), India (28 days), Nigeria (7 days), and Angola (7 days) [63, 6668]. Such a wide range of HSD among these countries demonstrates that HSD is still a big concern for TB treatment worldwide.

Only 15% of TB patients were diagnosed with TB when first attending a health care facility. The median number of visits to health care facilities prior to diagnosis of TB was four, which was almost similar to the report by Almeida et al. in 2015 [22]. While 93.1% of TB patients had reported the unusual sputum as their first symptoms prior to diagnosis of TB, the number of sputum smears requested by physicians was very low (14.5% of 66 TB patients). This is possibly because of a lack of awareness of TB symptoms among health care providers [69]. Our data also showed the 85% of the patients had a misdiagnosis when first attending health care facilities after the onset of TB-related symptoms. This is likely due to TB having similar symptoms to cold and other viral upper respiratory infections [70]. Current and previous studies show HSD is highly associated with more visits of health care facilities, and that this is likely also due to misdiagnosis at initial visit [36, 70]. The results of HSD highlight the importance of TB-related education for healthcare providers for addressing the challenges faced at TLDRC and other healthcare facilities in Tabriz, Iran.

Even though all the costs of diagnosis and treatment of TB are free in the TLDRC, only 15% of the patients attended TLDRC as their first action after the onset of TB symptoms. This is possibly because either the family physician referral system did not refer TB patients to the TLDRC due to misdiagnosis, lack of diagnostic awareness [71], or patients did not have any knowledge about the available services at the TB center. We believe that the long HSD before TB diagnosis and treatment in Tabriz needs to be reduced through improving quality and coverage of NTP [72]. Even though some patients reported different symptoms before TB diagnosis, none of them were significantly associated with PD or HSD. This could be related to either patients who seek care from informal health providers as an initial point of care or patients who self-medicate [73].

Although our study has elucidated, to some extent, the contributing potential factors associated with PD and HSD in Iran, some limitations need to be noted. In the current cross-sectional study, the sample is not representative of all TB patients in Iran; therefore, it is hard to generalize the results to the TB population Iran nationwide. Furthermore, the cross-sectional nature of our study does not allow us to deduce causality of the observed associations, and confounding variables could also mask the association. A larger nationwide sampling strategy should be pursued for future studies to explore the potential factors associated with PD and HSD in TB patients across Iran.

Conclusion

The study has identified the potential risk factors associated with HSD, PD, and OD in Tabriz, Iran. The understanding of the potential risk factors related to these delays can minimize the length of time between the onset of symptoms and correct diagnosis, and will help to initiate treatment as soon as possible. Integrating the TLDRC with the public hospital, to minimize the attending time and increasing the rate of correct diagnosis after onset of symptoms, and improving training program for local public health services, particularly in the PHC system, will help to reduce these delays in the studied area.

Declarations

Acknowledgments

The authors acknowledge all participants in this study, and acknowledge the staff of the Tuberculosis and Lung Diseases Research Center at the Tabriz University of Medical Science who helped to collect data.

Funding

This study was partly supported by the Student Research Center of Tabriz University of Medical Science (5/4/9632) in Iran, and the National Science Foundation (NSF) under Cooperative Agreement No. DBI-0939454. Any opinions, findings, and conclusions or recommendations expressed in this manuscript are those of the authors and do not necessarily reflect the views of the funding agency. The funders had no roles in the preparation of the manuscript.

Availability of data and materials

The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors’ contributions

MEK and HYS designed the study and collected data. VK, MEK, MAJ, SHH, and JH analyzed the data. JH, VK, SHH, HYS, GDG, and MEK participated in writing and editing of the manuscript. All authors have read and approved the final version of the manuscript.

Ethics approval and consent to participate

The study was approved by the Students Research Committee (No.5/46/210) and Ethical Regional Committee (No. 5/4/9632) of Tabriz University of Medical Sciences and Health Services, Tabriz, Iran. The Institutional Review Board at the North Carolina Agricultural and Technical State University (NCAT) received the approved letters. All participants were informed of the purpose of the study, and all participants signed the written consent form.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Biology, North Carolina Agricultural and Technical State University, Greensboro, NC 27411, USA
(2)
Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences and Health Services, Tabriz, East Azerbaijan, Iran
(3)
Road Traffic Injury Research Center, Tabriz University of Medical Sciences and Health Services, Tabriz, East Azerbaijan, Iran
(4)
Department of Statistics and Epidemiology, Faculty of Health, Tabriz University of Medical Sciences and Health Services, Tabriz, East Azerbaijan, Iran

References

  1. Bassili A, Seita A, Baghdadi S, AlAbsi A, Abdilai I, Agboatwalla M, Maamari F, Nasehi M, Nasir H, Soliman S, et al. Diagnostic and treatment delay in tuberculosis in 7 countries of the Eastern Mediterranean Region. Infect Dis Clin Pract. 2008;16(1):23–35.View ArticleGoogle Scholar
  2. World Health Organization. Global tuberculosis report. 2015. http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf. Accessed 20 Feb 2017.
  3. Nakajima H. Tuberculosis: a global emergency. World Health Organ. 1993;46(4):3.Google Scholar
  4. Glaziou P, Sismanidis C, Floyd K, Raviglione M. Global epidemiology of tuberculosis. Cold Spring Harbor Perspect Med. 2015;5(2):a017798.View ArticleGoogle Scholar
  5. Daniel TM. The history of tuberculosis. Respir Med. 2006;100(11):1862–70.View ArticlePubMedGoogle Scholar
  6. Mohajan HK. Tuberculosis is a Fatal Disease among Some Developing Countries of the World. Am J Infec Dis Microbiol. 2015;3(1):18–31.Google Scholar
  7. Raviglione MC. The new Stop TB Strategy and the Global Plan to Stop TB, 2006–2015. Bulletin of the World Health Organization. 2007;85(5):327.Google Scholar
  8. World Health Organization. Global TB report 2013. Geneva: WHO; 2013a.Google Scholar
  9. World Health Organization.Treatment of Tuberculosis: Guidelines. 4th edition. Geneva: World Health Organization; 2010. https://0-www-ncbi-nlm-nih-gov.brum.beds.ac.uk/books/NBK138748/. Accessed 18 Jan 2017.
  10. Jurcev-Savicevic A, Mulic R, Kozul K, Ban B, Valic J, Bacun-Ivcek L, Gudelj I, Popijac-Cesar G, Marinovic-Dunatov S, Simunovic A. Health system delay in pulmonary tuberculosis treatment in a country with an intermediate burden of tuberculosis: a cross-sectional study. BMC Public Health. 2013;13:250.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Needham DM, Foster SD, Tomlinson G, Godfrey-Faussett P. Socio-economic, gender and health services factors affecting diagnostic delay for tuberculosis patients in urban Zambia. Trop Med Int Health. 2001;6(4):256–9.View ArticlePubMedGoogle Scholar
  12. Khazaei S, Mansournia MA, Nematollahi S, Ayubi E, Zahiri A, Mohamadian-Hafshejani A, Ahmadi Pishkuhi M, Salehiniya H, khazaei S. Determinants of delay in tuberculosis diagnosis in Hamadan province, 2006−2014. Egypt J Chest Dis Tuberc. 2016;65(4):811–5.View ArticleGoogle Scholar
  13. Li Y, Ehiri J, Tang S, Li D, Bian Y, Lin H, Marshall C, Cao J. Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis. BMC Med. 2013;11:156.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Belkina TV, Khojiev DS, Tillyashaykhov MN, Tigay ZN, Kudenov MU, Tebbens JD, Vlcek J. Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study. BMC Infect Dis. 2014;14:624.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Laohasiriwong W, Mahato RK, Koju R. Health system delay among the pulmonary tuberculosis patients presenting in the DOTS centers of Nepal. J Clin Diagn Res. 2016;10(6):Lm01–3.PubMedPubMed CentralGoogle Scholar
  16. World Health Organization. Stop tuberculosis, epidemiological situation. Regional Office for Eastern Mediterranean. 2010. http://www.emro.who.int/tuberculosis/epidemiological-situation/epidemiological-situation.html. Accessed 18 Feb 2017.
  17. World Health Organization. Diagnostic and treatment delay in tuberculosis. Regional Office for Eastern Mediterranean, Cairo, Egypt. 2006. http://applications.emro.who.int/dsaf/dsa710.pdf. Accessed 18 Feb 2017.
  18. The World Bank Group. World Bank Country and Lending Groups. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Accessed 20 Mar 2017.
  19. Heshmati B, Joulaei H. Iran's health-care system in transition. Lancet. 2016;387(10013):29–30.View ArticlePubMedGoogle Scholar
  20. Rafiee S, Besharat S, Jabbari A, Golalipour F, Nasermoaadeli A. Epidemiology of Tuberculosis in Northeast of Iran: A Population-Based Study. Iran J Med Sci. 2009;34(3):193–7.Google Scholar
  21. Nasehi M, Hassanzadeh J, Rezaianzadeh A, Zeigami B, Tabatabaee H, Ghaderi E. Diagnosis delay in smear positive tuberculosis patients. J Res Med Sci. 2012;17(11):1001–4.PubMedPubMed CentralGoogle Scholar
  22. Almeida CP, Skupien EC, Silva DR. Health care seeking behavior and patient delay in tuberculosis diagnosis. Cadernos de saude publica. 2015;31(2):321–30.View ArticlePubMedGoogle Scholar
  23. Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health. 2008;8(1):15.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Ward J, Siskind V, Konstantinos A. Patient and health care system delays in Queensland tuberculosis patients, 1985-1998. Int J Tuberc Lung Dis. 2001;5(11):1021–7.PubMedGoogle Scholar
  25. Masjedi MR, Cheragvandi A, Hadian M, Velayati AA. Reasons for delay in the management of patients with pulmonary tuberculosis. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2002;8(2-3):324–9.Google Scholar
  26. Charkazi AR, Kouchaki G, Nejad MS, Gholizade AH. Medical interns' knowledge of tuberculosis and DOTS strategy in northern Islamic Republic of Iran. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2012;16(12):1251–6.Google Scholar
  27. Huong NT, Vree M, Duong BD, Khanh VT, Loan VT, Co NV, Borgdorff MW, Cobelens FG. Delays in the diagnosis and treatment of tuberculosis patients in Vietnam: a cross-sectional study. BMC Public Health. 2007;7:110.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Yang W-T, Gounder CR, Akande T, De Neve J-W, McIntire KN, Chandrasekhar A, de Lima PA, Gummadi N, Samanta S, Gupta A. Barriers and delays in tuberculosis diagnosis and treatment services: does gender matter? Tuberc Res Treat. 2014;2014:461935.PubMedPubMed CentralGoogle Scholar
  29. Ibrahim WH, Alousi FH, Al-Khal A, Bener A, AlSalman A, Aamer A, Khaled A, Raza T. Diagnostic delay among adults with pulmonary tuberculosis in a high gross domestic product per capita country: reasons and magnitude of the problem. Int J Prev Med. 2016;7:116.View ArticlePubMedPubMed CentralGoogle Scholar
  30. Gebreegziabher SB, Bjune GA, Yimer SA. Patients' and health system's delays in the diagnosis and treatment of new pulmonary tuberculosis patients in west Gojjam zone, Northwest Ethiopia: a cross-sectional study. BMC Infect Dis. 2016;16(1):673.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Saqib MA, Awan IN, Rizvi SK, Shahzad MI, Mirza ZS, Tahseen S, Khan IH, Khanum A. Delay in diagnosis of tuberculosis in Rawalpindi, Pakistan. BMC Res Notes. 2011;4:165.View ArticlePubMedPubMed CentralGoogle Scholar
  32. Anastasatu C, Burnea D, Avramescu D, Varachiu I. Reasons for delayed diagnosis of pulmonary tuberculosis. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1989;38(4):317–31.PubMedGoogle Scholar
  33. Sreeramareddy CT, Panduru KV, Menten J, Van den Ende J. Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature. BMC Infect Dis. 2009;9:91.View ArticlePubMedPubMed CentralGoogle Scholar
  34. Hussen A, Biadgilign S, Tessema F, Mohammed S, Deribe K, Deribew A. Treatment delay among pulmonary tuberculosis patients in pastoralist communities in bale zone, Southeast Ethiopia. BMC Res Notes. 2012;5:320.PubMedPubMed CentralGoogle Scholar
  35. Diez M, Bleda MJ, Alcaide J, Caloto T, Castells C, Cardenal JI, Dominguez A, Gayoso P, Gutierrez G, Huerta C, et al. Determinants of patient delay among tuberculosis cases in Spain. Eur J Pub Health. 2004;14(2):151–5.View ArticleGoogle Scholar
  36. Kiwuwa MS, Charles K, Harriet MK. Patient and health service delay in pulmonary tuberculosis patients attending a referral hospital: a cross-sectional study. BMC Public Health. 2005;5:122.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Diez M, Bleda MJ, Alcaide J, Castells C, Cardenal JI, Dominguez A, Gayoso P, Guitierrez G, Huerta C, Lopez MJ, et al. Determinants of health system delay among confirmed tuberculosis cases in Spain. Eur J Pub Health. 2005;15(4):343–9.View ArticleGoogle Scholar
  38. Cai J, Wang X, Ma A, Wang Q, Han X, Li Y. Factors associated with patient and provider delays for tuberculosis diagnosis and treatment in Asia: a systematic review and meta-analysis. PLoS One. 2015;10(3):e0120088.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Saifodine A, Gudo PS, Sidat M, Black J. Patient and health system delay among patients with pulmonary tuberculosis in Beira city. Mozambique BMC Public Health. 2013;13(1):559.View ArticlePubMedGoogle Scholar
  40. Ghozikali MG, Mosaferi M, Naddafi K. Environmental health problems and indicators in Tabriz, Iran. Health Promot Perspect. 2013;3(1):113–23.PubMedPubMed CentralGoogle Scholar
  41. Lacroix C, Martin P, Turcotte S, DeRoche S, Magluilo V, Lacroix C. The delay in diagnosis of tuberculosis in the Monteregie region of Quebec, Canada. McGill J Med. 2008;11(2):124–31.PubMedPubMed CentralGoogle Scholar
  42. Nasehi Mahshid ML. Iran’s national tuberculosis guideline. Tehran: Ministry of Health and Medical Education; 2010.Google Scholar
  43. Davies PD. The role of DOTS in tuberculosis treatment and control. Am J Respir Med. 2003;2(3):203–9.View ArticlePubMedGoogle Scholar
  44. Sreeramareddy CT, Qin ZZ, Satyanarayana S, Subbaraman R, Pai M. Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review. Int J Tuberc Lung Dis. 2014;18(3):255–66.View ArticlePubMedPubMed CentralGoogle Scholar
  45. David W. Hosmer J, Stanley Lemeshow, Rodney X. Sturdivant. Applied Logistic Regression. 3rd ed. Wiley; 2013.Google Scholar
  46. Gele AA, Bjune G, Abebe F. Pastoralism and delay in diagnosis of TB in Ethiopia. BMC Public Health. 2009;9(1):5.View ArticlePubMedPubMed CentralGoogle Scholar
  47. Belay M, Bjune G, Ameni G, Abebe F. Diagnostic and treatment delay among tuberculosis patients in afar region, Ethiopia: a cross-sectional study. BMC Public Health. 2012;12(1):369.View ArticlePubMedPubMed CentralGoogle Scholar
  48. Gagliotti C, Resi D, Moro ML. Delay in the treatment of pulmonary TB in a changing demographic scenario. Int J Tuberc Lung Dis. 2006;10(3):305–9.PubMedGoogle Scholar
  49. Liam CK, Tang BG. Delay in the diagnosis and treatment of pulmonary tuberculosis in patients attending a university teaching hospital. Int J Tuberc Lung Dis. 1997;1(4):326–32.PubMedGoogle Scholar
  50. Yimer S, Bjune G, Alene G. Diagnostic and treatment delay among pulmonary tuberculosis patients in Ethiopia: a cross sectional study. BMC Infect Dis. 2005;5:112.View ArticlePubMedPubMed CentralGoogle Scholar
  51. Mirsaeidi SM, Tabarsi P, Mohajer K, Falah-Tafti S, Jammati HR, Farnia P, Mansouri SD, Masjedi MR, Velayati AA. A long delay from the first symptom to definite diagnosis of pulmonary tuberculosis. Arch Iran Med. 2007;10(2):190–3.PubMedGoogle Scholar
  52. Wandwalo ER, Morkve O. Delay in tuberculosis case-finding and treatment in Mwanza, Tanzania. Int J Tuberc Lung Dis. 2000;4(2):133–8.PubMedGoogle Scholar
  53. Lin Y, Enarson DA, Chiang CY, Rusen ID, Qiu LX, Kan XH, Yuan YL, Du J, Zhang TH, Li Y, et al. Patient delay in the diagnosis and treatment of tuberculosis in China: findings of case detection projects. Public Health Action. 2015;5(1):65–9.View ArticlePubMedPubMed CentralGoogle Scholar
  54. Basnet R, Hinderaker SG, Enarson D, Malla P, Mørkve O. Delay in the diagnosis of tuberculosis in Nepal. BMC Public Health. 2009;9(1):236.View ArticlePubMedPubMed CentralGoogle Scholar
  55. Chiang CY, Chang CT, Chang RE, Li CT, Huang RM. Patient and health system delays in the diagnosis and treatment of tuberculosis in southern Taiwan. Int J Tuberc Lung Dis. 2005;9(9):1006–12.PubMedGoogle Scholar
  56. Rajeswari R, Chandrasekaran V, Suhadev M, Sivasubramaniam S, Sudha G, Renu G. Factors associated with patient and health system delays in the diagnosis of tuberculosis in South India. Int J Tuberc Lung Dis. 2002;6(9):789–95.PubMedGoogle Scholar
  57. Tobgay KJ, Sarma PS, Thankappan KR. Predictors of treatment delays for tuberculosis in Sikkim. Natl Med J India. 2006;19(2):60–3.PubMedGoogle Scholar
  58. Ben Amar J, Hassairi M, Ben Salah N, Charfi R, Tritar F, Fourati R, Gamara D, Aouina H, Bouacha H. Pulmonary tuberculosis: diagnostic delay in Tunisia. Medecine et maladies infectieuses. 2016;46(2):79–86.View ArticlePubMedGoogle Scholar
  59. Zerbini E, Chirico MC, Salvadores B, Amigot B, Estrada S, Algorry G. Delay in tuberculosis diagnosis and treatment in four provinces of Argentina. Int J Tuberc Lung Dis. 2008;12(1):63–8.PubMedGoogle Scholar
  60. Alavi SM, Bakhtiyariniya P, Albagi A. Factors associated with delay in diagnosis and treatment of pulmonary tuberculosis. Jundishapur J Microbiol. 2015;8(3):e19238.View ArticlePubMedPubMed CentralGoogle Scholar
  61. Farah MG, Rygh JH, Steen TW, Selmer R, Heldal E, Bjune G. Patient and health care system delays in the start of tuberculosis treatment in Norway. BMC Infect Dis. 2006;6Google Scholar
  62. Long NH, Johansson E, Lonnroth K, Eriksson B, Winkvist A, Diwan VK. Longer delays in tuberculosis diagnosis among women in Vietnam. Int J Tuberc Lung Dis. 1999;3(5):388–93.PubMedGoogle Scholar
  63. Purty AJ, Chauhan RC, Natesan M, Cherian J, Singh Z, Sharma Y. Patient and health system delays among adult smear-positive tuberculosis patients diagnosed at medical colleges of Puducherry in south India. Indian J Public Health. 2016;60(1):77–80.View ArticlePubMedGoogle Scholar
  64. Calder L, Gao W, Simmons G. Tuberculosis: reasons for diagnostic delay in Auckland. N Z Med J. 2000;113(1122):483–5.PubMedGoogle Scholar
  65. Caceres-Manrique Fde M, Orozco-Vargas LC. Delayed diagnosis of pulmonary tuberculosis in a particular part of Colombia. Revista de salud publica (Bogota, Colombia). 2008;10(1):94–104.View ArticleGoogle Scholar
  66. Chen CC, Chiang CY, Pan SC, Wang JY, Lin HH. Health system delay among patients with tuberculosis in Taiwan: 2003-2010. BMC Infect Dis. 2015;15:491.View ArticlePubMedPubMed CentralGoogle Scholar
  67. Odusanya OO, Babafemi JO. Patterns of delays amongst pulmonary tuberculosis patients in Lagos, Nigeria. BMC Public Health. 2004;4(1):18.View ArticlePubMedPubMed CentralGoogle Scholar
  68. Segagni Lusignani L, Quaglio G, Atzori A, Nsuka J, Grainger R, Palma Mda C, Putoto G, Manenti F. Factors associated with patient and health care system delay in diagnosis for tuberculosis in the province of Luanda, Angola. BMC Infect Dis. 2013;13:168.View ArticlePubMedPubMed CentralGoogle Scholar
  69. Vandan N, Ali M, Prasad R, Kuroiwa C. Assessment of doctors' knowledge regarding tuberculosis management in Lucknow, India: a public-private sector comparison. Public Health. 2009;123(7):484–9.View ArticlePubMedGoogle Scholar
  70. Davies PD, Pai M. The diagnosis and misdiagnosis of tuberculosis. Int J Tuberc Lung Dis. 2008;12(11):1226–34.PubMedGoogle Scholar
  71. Demissie M, Lindtjorn B, Berhane Y. Patient and health service delay in the diagnosis of pulmonary tuberculosis in Ethiopia. BMC Public Health. 2002;2:23.View ArticlePubMedPubMed CentralGoogle Scholar
  72. Dujardin B, Kegels G, Buve A, Mercenier P. Tuberculosis control: did the programme fail or did we fail the programme? Trop Med Int Health. 1997;2(8):715–8.View ArticlePubMedGoogle Scholar
  73. Paz-Soldan VA, Alban RE, Dimos Jones C, Powell AR, Oberhelman RA. Patient reported delays in seeking treatment for tuberculosis among adult and pediatric TB patients and TB patients co-infected with HIV in lima, Peru: a qualitative study. Front Public Health. 2014;2:281.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement